{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:08:08Z","timestamp":1791932888163,"version":"4.3.4"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Finnish Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Helsinki and Uusimaa Hospital District"},{"DOI":"10.13039\/501100013815","name":"Cancer Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013815","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C569\/A10404"],"award-info":[{"award-number":["C569\/A10404"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is no prognostic test to ascertain whether cervical intraepithelial neoplasias (CINs) regress or progress. The majority of CINs regress in young women, and treatments increase the risk of adverse pregnancy outcomes. We investigated the ability of a DNA methylation panel (the S5 classifier) to discriminate between outcomes among young women with untreated CIN grade 2 (CIN2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Baseline pyrosequencing methylation and human papillomavirus (HPV) genotyping assays were performed on cervical cells from 149 women with CIN2 in a 2-year cohort study of active surveillance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-five lesions progressed to CIN grade 3 or worse, 88 regressed to less than CIN grade 1, and 36 persisted as CIN1\/2. When cytology, HPV16\/18 and HPV16\/18\/31\/33 genotyping, and the S5 classifier were compared to outcomes, the S5 classifier was the strongest biomarker associated with regression vs progression. The S5 classifier alone or in combination with HPV16\/18\/31\/33 genotyping also showed significantly increased sensitivity vs cytology when comparing regression vs persistence\/progression. With both the S5 classifier and cytology set at a specificity of 38.6% (95% confidence interval [CI], 28.4\u201349.6), the sensitivity of the S5 classifier was significantly higher (83.6%; 95% CI, 71.9\u201391.8) than of cytology (62.3%; 95% CI, 49.0\u201374.4; P = 0.005). The highest area under the curve was 0.735 (95% CI, 0.621\u20130.849) in comparing regression vs progression with a combination of the S5 classifier and cytology, whereas HPV genotyping did not provide additional information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The S5 classifier shows high potential as a prognostic biomarker to identify progressive CIN2.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciz677","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T07:25:44Z","timestamp":1563953144000},"page":"2582-2590","source":"Crossref","is-referenced-by-count":85,"title":["Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia"],"prefix":"10.1093","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-363X","authenticated-orcid":false,"given":"Karolina","family":"Louvanto","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Turku University Hospital, University of Turku, Turku, Finland"},{"name":"Center for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom"},{"name":"Department of Obstetrics and Gynecology, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoliina","family":"Aro","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Nedjai","sequence":"first","affiliation":[{"name":"Center for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"B\u00fctzow","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"Jakobsson","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Kalliala","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Finland"},{"name":"Department of Surgery & Cancer, Institute of Reproductive and Developmental Biology, Faculty of Medicine, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Dillner","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Nieminen","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Lorincz","sequence":"first","affiliation":[{"name":"Center for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"2020061010552445000_CIT0001","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"2020061010552445000_CIT0002","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"key":"2020061010552445000_CIT0003","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"key":"2020061010552445000_CIT0004","doi-asserted-by":"crossref","first-page":"k499","DOI":"10.1136\/bmj.k499","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis","volume":"360","author":"Tainio","year":"2018","journal-title":"BMJ"},{"key":"2020061010552445000_CIT0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"2020061010552445000_CIT0006","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","article-title":"Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis","volume":"337","author":"Arbyn","year":"2008","journal-title":"BMJ"},{"key":"2020061010552445000_CIT0007","doi-asserted-by":"crossref","first-page":"i3633","DOI":"10.1136\/bmj.i3633","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","volume":"354","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"key":"2020061010552445000_CIT0008","first-page":"CD012847","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease","volume":"11","author":"Kyrgiou","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2020061010552445000_CIT0009","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/AOG.0b013e3181fe777f","article-title":"Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women","volume":"116","author":"Moscicki","year":"2010","journal-title":"Obstet Gynecol"},{"key":"2020061010552445000_CIT0010","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"key":"2020061010552445000_CIT0011","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e3181e8b2c4","article-title":"Using biomarkers as objective standards in the diagnosis of cervical biopsies","volume":"34","author":"Galgano","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"2020061010552445000_CIT0012","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1525-1438.2007.00899.x","article-title":"p16(INK4a) expression does not predict the outcome of cervical intraepithelial neoplasia grade 2","volume":"17","author":"Guedes","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"2020061010552445000_CIT0013","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1309\/0UP5PJK9RYF7BPHM","article-title":"Estimation of prognoses for cervical intraepithelial neoplasia 2 by p16INK4a immunoexpression and high-risk HPV in situ hybridization signal types","volume":"128","author":"Omori","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"2020061010552445000_CIT0014","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/ijc.27750","article-title":"Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia","volume":"132","author":"Mirabello","year":"2013","journal-title":"Int J Cancer"},{"key":"2020061010552445000_CIT0015","doi-asserted-by":"crossref","first-page":"E638","DOI":"10.1002\/ijc.29196","article-title":"Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16","volume":"136","author":"Louvanto","year":"2015","journal-title":"Int J Cancer"},{"key":"2020061010552445000_CIT0016","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/1940-6207.CAPR-14-0237","article-title":"Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2\/3 lesions","volume":"7","author":"De Strooper","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"2020061010552445000_CIT0017","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.virol.2013.10.032","article-title":"Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: considerations for use as biomarkers of the progression of cervical neoplasia","volume":"448","author":"Kalantari","year":"2014","journal-title":"Virology"},{"key":"2020061010552445000_CIT0018","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ijc.30781","article-title":"Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer","volume":"141","author":"Clarke","year":"2017","journal-title":"Int J Cancer"},{"key":"2020061010552445000_CIT0019","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/ijc.30008","article-title":"Validation of a DNA methylation HPV triage classifier in a screening sample","volume":"138","author":"Lorincz","year":"2016","journal-title":"Int J Cancer"},{"key":"2020061010552445000_CIT0020","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/ijc.28790","article-title":"A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes","volume":"135","author":"Brentnall","year":"2014","journal-title":"Int J Cancer"},{"key":"2020061010552445000_CIT0021","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3233\/CBM-150507","article-title":"HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \\textit{EPB41L3} methylation classifier","volume":"15","author":"Brentnall","year":"2015","journal-title":"Cancer Biomark"},{"key":"2020061010552445000_CIT0022","volume-title":"Cytological changes in the cervix, vagina and vulva (online)","author":"Group set up by the Finnish Medical Society Duodecim, the Finnish Colposcopy Association","year":"2016"},{"key":"2020061010552445000_CIT0023","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-006-9242-8","article-title":"REporting recommendations for tumor MARKer prognostic studies (REMARK)","volume":"100","author":"McShane","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"2020061010552445000_CIT0024","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/JCM.02007-08","article-title":"Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus","volume":"47","author":"S\u00f6derlund-Strand","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2020061010552445000_CIT0025","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ygyno.2014.02.001","article-title":"Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women","volume":"132","author":"Vasiljevi\u0107","year":"2014","journal-title":"Gynecol Oncol"},{"key":"2020061010552445000_CIT0026","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcv.2013.12.014","article-title":"A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers","volume":"59","author":"Vasiljevi\u0107","year":"2014","journal-title":"J Clin Virol"},{"key":"2020061010552445000_CIT0027","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/ijc.28790","article-title":"A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes","volume":"135","author":"Brentnall","year":"2014","journal-title":"Int J Cancer"},{"key":"2020061010552445000_CIT0028","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1097\/QAD.0000000000001932","article-title":"Associations of human gene EPB41L3 DNA methylation and cervical intraepithelial neoplasia in women living with HIV-1 in Africa","volume":"32","author":"Kelly","year":"2018","journal-title":"AIDS"},{"key":"2020061010552445000_CIT0029","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/bmj.298.6675.707","article-title":"Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia","volume":"298","author":"Ismail","year":"1989","journal-title":"BMJ"},{"key":"2020061010552445000_CIT0030","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"2020061010552445000_CIT0031","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int J Gynecol Pathol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz677\/30051022\/ciz677.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/70\/12\/2582\/33375389\/ciz677.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/70\/12\/2582\/33375389\/ciz677.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T13:36:09Z","timestamp":1591796169000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/70\/12\/2582\/5538807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,7,25]]},"published-print":{"date-parts":[[2020,6,10]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz677","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6,15]]},"published":{"date-parts":[[2019,7,25]]}}}